Following these studies, Zhang et al. [85] demonstrated that CD44+CD117+ cells have the potential to initiate epithelial ovarian cancer, which was later supported by other studies as well [55, 86, 87]. This evidence concerns the gene CD44 and ovarian carcinoma.